-
New therapeutic target discovered for treatment-resistant melanoma
08 Jun 2024 07:18 GMT
… target for the treatment of melanoma resistant to targeted therapies. Inhibition … . secondary distant tumours) have developed, melanoma becomes difficult to treat, limiting … for patients suffering from resistant melanoma. The researchers will be continuing …
-
How an Aussie woman is using her shock melanoma diagnosis to help pay for a European holiday
08 Jun 2024 06:22 GMT
… to be diagnosed with genetic melanoma.
The 35-year-old was …
-
Michael Mosley thought he had melanoma. His actual diagnosis sparked a diet trend that swept the globe
08 Jun 2024 03:25 GMT
… was worried about a possible melanoma on his skin that had …
-
Patients With Stage 3 Melanoma Should Discuss Adjuvant Therapy
08 Jun 2024 00:39 GMT
… with resectable stage 3 melanoma should be talking with … in with resectable stage 3 melanoma that's clinically … Long is the chair of melanoma medical oncology and translational research … cell growth, according to the Melanoma Research Alliance. The drug …
-
RP1/Nivolumab Yields Responses in Previously Treated Melanoma
07 Jun 2024 18:22 GMT
… third of patients with melanoma who have progressed on … this population.
Overall, the melanoma cohort of the trial included … . For those with cutaneous melanoma that has progressed on prior … nivolumab in anti-PD1 failed melanoma. News release. Replimune Group, …
-
Mayo Clinic Minute: Melanoma misconception: Dark skin tones at risk, too
07 Jun 2024 17:48 GMT
… dark skin are immune to melanoma, a type of skin cancer … to reduce the risk of melanoma
The longer you’re exposed …
-
Replimune ignites its stock with phase I data in melanoma
07 Jun 2024 02:15 GMT
… ), in anti-PD-1-failed melanoma. Data from the phase I …
-
Melanoma warning: Cincinnati ultra-marathoner advocates for annual skin checks
06 Jun 2024 23:51 GMT
… ANYTIME ANYBODY FIRST GETS A MELANOMA DIAGNOSIS, THEY HEAR, YOU … THANKS TO THAT CHECKUP. IF MELANOMA IS LOCALIZED, YOU KNOW, … OUTDOORS TO BE MINDFUL. MELANOMA IS MOST COMMON IN LIGHTER … IT’S BEST TO GET
Melanoma warning: Cincinnati ultra-marathoner advocates …
-
Highly Significant Event Free Survival Benefit With Neoadjuvant Ipilimumab/Nivolumab in Stage 3 Melanoma
06 Jun 2024 20:33 GMT
… patients with macroscopic stage 3 melanoma, compared to standard adjuvant nivolumab … of resectable, macroscopic stage 3 melanoma is currently surgery, which can … with resectable, macroscopic stage 3 melanoma. Nearly 60% of patients in …
-
New Data With RP1 Plus Nivolumab in PD-1–Refractory Melanoma Build on Positive Findings
06 Jun 2024 18:07 GMT
… activity in patients with melanoma who failed prior anti– … enrolled patients with advanced melanoma who experienced disease progression … PD-1-failed cutaneous melanoma cohort, patients received the … in anti-PD1 failed melanoma. News release. Replimune Group …